News
Stephen Frye receives Maximizing Investigators’ Research Award, tops $2 million, supports small molecule research to identify new approaches to modulating drug targets
Each day, Stephen Frye, Ph.D., works to identify pharmacologic approaches to intervene in novel drug targets within the human body with the goal of creating new therapeutic interventions that will directly aid patients. Today, he’s pushing his work further with … Read more
Wang receives $2.5 million grant to further novel cancer treatment research
Xiaodong Wang, Ph.D., has received a selective $2.5 million R01 grant from the National Institutes of Health to research and develop a new treatment for targeting tumor cells. Wang is a research associate professor at the UNC Eshelman School of … Read more
Pinnacle Hill Announces First Project Agreement
Alliance Between UNC-Chapel Hill and Deerfield intends to advance select Carolina innovations toward a possible new treatment against multiple myeloma Pinnacle Hill, the research and development partnership between the University of North Carolina at Chapel Hill and Deerfield Management Company, … Read more
Researchers develop data-driven strategy to discover cancer therapies
Drug discoverers Dmitri Kireev, Ph.D., and Xiaodong Wang, Ph.D., of the UNC Eshelman School of Pharmacy have created a data-driven strategy to be able to treat diseases such as acute myeloid leukemia and nonsmall cell lung cancer. Kireev said controlling … Read more
New NIH proposal aims to advance Alzheimer’s drug discovery research
(Photo courtesy of Stephen Frye) A group of researchers from the University of North Carolina at Chapel Hill are part of a new research proposal to create chemical and biological tools to explore novel molecular targets related to Alzheimer’s disease. … Read more
Albert Bowers Promoted to Associate Professor
Albert Bowers, Ph.D., a faculty member in the Division of Chemical Biology and Medicinal Chemistry, has been promoted to the rank of associate professor at the UNC Eshelman School of Pharmacy. Bowers is a member of the UNC Lineberger Comprehensive … Read more
Researchers Discover Compound with Potential to Stop Cancer Metastasis
A UNC Eshelman School of Pharmacy scientist is a leader in a large research collaboration that has discovered a new compound that suppressed the spread of cancer — a process known as metastasis — in three different animal models of … Read more
Bowers Receives $1.9 M NIGMS Outstanding Investigator Award
Albert Bowers, Ph.D., has received a R35 Outstanding Investigator Award worth more than $1.9 million over five years from the National Institute of General Medical Sciences to study the chemoenzymatic synthesis, mode of action and evolution of natural product-based macrocycles. … Read more